What’s news from ATCC?
ATCC has updated the White Paper Synthetic Nucleic Acids for the Development and Evaluation of In Vitro Diagnostic Devices Designed to Detect Dengue, Chikungunya, and Zika White Paper.
Eradicate Cancer Travel Grant Winners
To support Australian and New Zealand research in the fight against cancer, In Vitro Technologies offered 5 Travel Grants to Australian and New Zealand researchers to attend the Eradicate Cancer Conference in Melbourne in March 2018. And the winners are...
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Great publication about improving the efficacy of adoptive T-Cell therapy in solid tumours by using 3rd generation CAR-T cells.
Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types
Scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher
In Vitro Technologies would like to congratulate Dr. Andreas Behren and the Cancer Immunobiology team at the Olivia Newton-John Cancer Research (ONJCRI) Institute in Melbourne for winning the Advanced Cell Diagnostics $40,000 USD research grant.
Biggest biobank in the southern hemisphere to revolutionise medical research in NSW
In Vitro Technologies are proud to work closely with the new NSW Health Statewide Biobank, the largest biobank in the southern hemisphere.
Betting Twelve Billion Dollars on Cellular Immunotherapy
In the latest vote of confidence that cellular immunotherapy is going to live up to its potential for transforming the way cancer is treated, this week Gilead Sciences purchased Kite Pharma, a leader in the development of chimeric antigen receptor (CAR) T cells, for $11.9 billion dollars.
Proteome Profilers for monitoring Host Response to infection
Proteome Profilerâ„¢ Antibody Arrays allow for the measurement of up to 119 proteins in a single sample.
ATCC® answers world health organization's call to arms in the race against antimicrobial resistance.
MANASSAS, VA (August 8, 2017) — ATCC, a global leader in biological materials development, management, and standards, in partnership with the Institute for Life Science Entrepreneurship (ILSE) and the ATCC...
See the new Minifors 2 at PEWS.
Join us at the Protein Expression Workshop meeting for a hands-on demonstration of the new Minifors 2 from Infors-HT and the new eve bioprocess control software.Â